Trial Outcomes & Findings for Familial Hyperlipidemia Family Registry (NCT NCT05814419)

NCT ID: NCT05814419

Last Updated: 2025-12-19

Results Overview

Individuals with elevated cholesterol group with familial hypercholesterolemia genotype.

Recruitment status

COMPLETED

Target enrollment

11 participants

Primary outcome timeframe

The duration of participation in study is one day.

Results posted on

2025-12-19

Participant Flow

Participant milestones

Participant milestones
Measure
Observational Registry Cohort
If a child from the Healthy Hearts and Minds education and screening program is found to have a genetic marker for familial hyperlipidemia, immediate family members are offered genetic testing at no charge to identify those at high risk for cardiovascular disorders and those who carry the genetic markers. If identified early, the risk for cardiovascular disease can be greatly modified by early and proper treatment. The aim of the study is to gauge the impact of large-scale surveillance testing to identify those with the disorder and improve clinical care. This impact is both in disease prevention and in lessening the cost of long-term care from premature cardiovascular disease. Family members of children identified in the Health Hearts screening program were enrolled in this study; Children in the Healthy Hearts screening program were enrolled in NCT05767996
Overall Study
STARTED
11
Overall Study
COMPLETED
11
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Familial Hyperlipidemia Family Registry

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Observational Registry Cohort
n=11 Participants
The aim of the study is to identify children and families that are at risk for cardiovascular disease because of a condition known as familial hyperlipidemia. This condition may increase the risk of cardiac events such as hardening of the arteries anywhere in the body which can result in heart attacks, strokes, and death over ten fold. Children have already been assessed in the Healthy Hearts screening program and identified as having elevated cholesterol. A buccal smear will identify whether the familial hyperlipidemia condition exist in your child. If the child's test shows that they have the specific gene for familial hyperlipidemia and shows a genetic tendency towards premature heart disease, we would encourage genetic testing for as many blood family members as possible. The study plan is to determine whether the Healthy Hearts screening program is a more effective way of identifying students at risk since it is estimated that less than 10% of those individuals with the problem have been identified. If it is effective, then it will be incorporated as part of the standard screening process in the Healthy Hearts program.
Age, Categorical
<=18 years
5 Participants
n=8 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
n=8 Participants
Age, Categorical
>=65 years
0 Participants
n=8 Participants
Sex: Female, Male
Female
5 Participants
n=8 Participants
Sex: Female, Male
Male
6 Participants
n=8 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=8 Participants
Race (NIH/OMB)
Asian
0 Participants
n=8 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=8 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=8 Participants
Race (NIH/OMB)
White
5 Participants
n=8 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=8 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants
n=8 Participants
Region of Enrollment
United States
11 participants
n=8 Participants

PRIMARY outcome

Timeframe: The duration of participation in study is one day.

Population: Individuals with elevated cholesterol group with familial hypercholesterolemia genotype. Not enough subjects participating to allow statistical analysis.

Individuals with elevated cholesterol group with familial hypercholesterolemia genotype.

Outcome measures

Outcome measures
Measure
Observational Registry Cohort
n=11 Participants
If a child from the Healthy Hearts and Minds education and screening program is found to have a genetic marker for familial hyperlipidemia, immediate family members are offered genetic testing at no charge to identify those at high risk for cardiovascular disorders and those who carry the genetic markers. If identified early, the risk for cardiovascular disease can be greatly modified by early and proper treatment. The aim of the study is to gauge the impact of large-scale surveillance testing to identify those with the disorder and improve clinical care. This impact is both in disease prevention and in lessening the cost of long-term care from premature cardiovascular disease. Family members of children identified in the Health Hearts screening program were enrolled in this study; Children in the Healthy Hearts screening program were enrolled in NCT05767996
Familial Hypercholesterolemia (FH) Determination for Family Members of School Children With Elevated Cholesterol and Documented FH Variant
Positive
3 participants
Familial Hypercholesterolemia (FH) Determination for Family Members of School Children With Elevated Cholesterol and Documented FH Variant
Negative
8 participants

Adverse Events

Adverse Events

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Gary J Luckasen, MD

UCHealth

Phone: 970-624-1680

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place